Multi-omics and functional studies reveal that NHE7 drives tumor progression in endometrial cancer by suppressing senescence via cAMP/GRIN2B-mediated Ca²⁺ influx and identify NHE7 as a prognostic biomarker and therapeutic target.
- Shizhou Yang
- Tao Shen
- Xiufeng Huang